PMC:7543798 / 110-970
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T2 | 52-60 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T3 | 459-467 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T4 | 605-613 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T5 | 849-859 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 354-355 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T2 | 436-444 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | actively |
| T3 | 583-584 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 595-600 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T2 | 713-721 | Chemical | denotes | medicine | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 6 | 52-62 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 7 | 459-467 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 8 | 605-613 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 9 | 849-859 | Disease | denotes | infections | MESH:D007239 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4 | 0-9 | Sentence | denotes | Abstract. |
| T5 | 10-195 | Sentence | denotes | The emergence and international spread of SARS-CoV-2 led to unprecedented challenges for international travelers including health-related concerns and international travel restrictions. |
| T6 | 196-645 | Sentence | denotes | Remarkably, overseas travelers consulted at our travel clinic during the first quarter of 2020 were apparently not disconcerted by the evolving pandemic with a continuously high rate of consultations at our center; 85% of travelers did not actively inquire about COVID-19 during the pretravel consultation including individuals with clinically significant immunosuppression constituting a high-risk group for COVID-19–related adverse health outcome. |
| T7 | 646-860 | Sentence | denotes | This experience demonstrates the societal responsibility of travel medicine practitioners to proactively provide unbiased information about the health-related and travel-related impact of newly emerging infections. |